Advanced search
Publication Cover
Journal of Hepatocellular Carcinoma Volume 9, 2022 - Issue
Submit an article Journal homepage
180
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Safety and Efficacy of Transarterial Chemoembolization and Immune Checkpoint Inhibition with Camrelizumab for Treatment of Unresectable Hepatocellular Carcinoma

Jin-Xing Zhang1 Department of Interventional Radiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, 210029, People’s Republic of ChinaView further author information
,
Pei Chen2 Department of Basic Medicine, Jiangsu College of Nursing, Huai’an, 223005, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-5763-7390View further author information
ORCID Icon,
Sheng Liu1 Department of Interventional Radiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, 210029, People’s Republic of ChinaView further author information
,
Qing-Quan Zu1 Department of Interventional Radiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, 210029, People’s Republic of ChinaView further author information
,
Hai-Bin Shi1 Department of Interventional Radiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, 210029, People’s Republic of ChinaCorrespondence[email protected] [email protected]
View further author information
&
Chun-Gao Zhou1 Department of Interventional Radiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, 210029, People’s Republic of ChinaView further author information
Pages 265-272 | Published online: 31 Mar 2022

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Jin-Tao Huang, Bin-Yan Zhong, Nan Jiang, Wan-Ci Li, Shuai Zhang, Yu Yin, Jun Yang, Jian Shen, Wan-Sheng Wang & Xiao-Li Zhu. (2022) Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors versus Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 9, pages 1217-1228.
Read now
Liang Yin, Kai-Cai Liu, Wei-Fu Lv, Shao-Bao Xu, Dong Lu, Chun-Ze Zhou, De-Lei Cheng, Zong-Gen Gao, Chang-Sheng Shi & Ming-Xue Su. (2022) Predicting Outcome in Combination Treatment of TACE and Camrelizumab for Advanced Hepatocellular carcinoma: Tumor Hypervascularity and Reactive Cutaneous Capillary Endothelial Proliferation. Drug Design, Development and Therapy 16, pages 3421-3429.
Read now

Articles from other publishers (7)

Xiaohong Li, Muhammad Wajid Ullah, Basen Li & Hangrong Chen. (2023) Recent Progress in Advanced Hydrogel‐Based Embolic Agents: From Rational Design Strategies to Improved Endovascular Embolization. Advanced Healthcare Materials 12:17.
Crossref
Nicolò Brandi & Matteo Renzulli. (2023) The Synergistic Effect of Interventional Locoregional Treatments and Immunotherapy for the Treatment of Hepatocellular Carcinoma. International Journal of Molecular Sciences 24:10, pages 8598.
Crossref
Qin Shi, Xin Zhou, Zihan Zhang, Wen Zhang, Jingqin Ma, Minjie Yang, Jiaze Yu, Jianjun Luo, Lingxiao Liu & Zhiping Yan. (2023) Microwave ablation and synchronous transarterial chemoembolization combined with PD-1 inhibitor in patients with hepatocellular carcinoma following tyrosine kinase inhibitor intolerance. Frontiers in Immunology 13.
Crossref
Huimin Zou, Qing Lei, Xin Yan, Yunfeng Lai, Carolina Oi Lam Ung & Hao Hu. (2022) Clinical Outcomes Associated with Monotherapy and Combination Therapy of Immune Checkpoint Inhibitors as First-Line Treatment for Advanced Hepatocellular Carcinoma in Real-World Practice: A Systematic Literature Review and Meta-Analysis. Cancers 15:1, pages 260.
Crossref
Jingxin Yan, Manjun Deng, Shunyu Kong, Ting Li, Zhenwu Lei, Lushun Zhang, Yutong Zhuang, Xin He, Huanwei Wang, Haining Fan & Yingxing Guo. (2022) Transarterial chemoembolization in combination with programmed death-1/programmed cell death-ligand 1 immunotherapy for hepatocellular carcinoma: A mini review. iLIVER 1:4, pages 225-234.
Crossref
Jin-Xing Zhang, Yu-Xing Chen, Chun-Gao Zhou, Jin Liu, Sheng Liu, Hai-Bin Shi & Qing-Quan Zu. (2022) Efficacy and Safety of the Combination of Transarterial Chemoembolization with Camrelizumab plus Apatinib for Advanced Hepatocellular Carcinoma: A Retrospective Study of 38 Patients from a Single Center. Canadian Journal of Gastroenterology and Hepatology 2022, pages 1-6.
Crossref
. (2022) Camrelizumab. Reactions Weekly 1907:1, pages 120-120.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.